Utah Medical Products, Inc. (NASDAQ:UTMD - Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $56.37 and traded as high as $57.93. Utah Medical Products shares last traded at $55.48, with a volume of 75,770 shares changing hands.
Utah Medical Products Price Performance
The firm's fifty day moving average price is $56.53 and its two-hundred day moving average price is $56.28. The stock has a market cap of $184.54 million, a price-to-earnings ratio of 15.37 and a beta of 0.31.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last posted its earnings results on Thursday, July 24th. The medical instruments supplier reported $0.94 earnings per share for the quarter. Utah Medical Products had a net margin of 32.34% and a return on equity of 10.55%. The company had revenue of $9.95 million for the quarter.
Utah Medical Products Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, October 2nd. Investors of record on Wednesday, September 17th will be issued a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Wednesday, September 17th. Utah Medical Products's dividend payout ratio is currently 32.62%.
Institutional Investors Weigh In On Utah Medical Products
A number of institutional investors and hedge funds have recently made changes to their positions in UTMD. LPL Financial LLC acquired a new stake in shares of Utah Medical Products in the 4th quarter worth about $208,000. Geode Capital Management LLC raised its holdings in shares of Utah Medical Products by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 97,937 shares of the medical instruments supplier's stock worth $6,022,000 after acquiring an additional 857 shares during the last quarter. Wells Fargo & Company MN raised its holdings in shares of Utah Medical Products by 24.9% in the 4th quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock worth $118,000 after acquiring an additional 384 shares during the last quarter. Envestnet Asset Management Inc. raised its holdings in shares of Utah Medical Products by 11.3% in the 4th quarter. Envestnet Asset Management Inc. now owns 7,373 shares of the medical instruments supplier's stock worth $453,000 after acquiring an additional 750 shares during the last quarter. Finally, Barclays PLC raised its holdings in shares of Utah Medical Products by 15.5% in the 4th quarter. Barclays PLC now owns 5,283 shares of the medical instruments supplier's stock worth $325,000 after acquiring an additional 709 shares during the last quarter. Institutional investors and hedge funds own 69.60% of the company's stock.
Utah Medical Products Company Profile
(
Get Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Recommended Stories
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
